Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

CV Sciences (CVSI) Cost of Revenue (2016 - 2025)

CV Sciences' Cost of Revenue history spans 13 years, with the latest figure at $1.7 million for Q3 2025.

  • For Q3 2025, Cost of Revenue fell 19.65% year-over-year to $1.7 million; the TTM value through Sep 2025 reached $6.0 million, up 386.55%, while the annual FY2024 figure was $8.5 million, 178.53% up from the prior year.
  • Cost of Revenue for Q3 2025 was $1.7 million at CV Sciences, up from $88000.0 in the prior quarter.
  • Across five years, Cost of Revenue topped out at $3.5 million in Q4 2024 and bottomed at -$3.8 million in Q4 2023.
  • The 5-year median for Cost of Revenue is $2.2 million (2023), against an average of $1.9 million.
  • The largest annual shift saw Cost of Revenue crashed 264.5% in 2023 before it surged 192.44% in 2024.
  • A 5-year view of Cost of Revenue shows it stood at $3.4 million in 2021, then plummeted by 31.32% to $2.3 million in 2022, then plummeted by 264.5% to -$3.8 million in 2023, then surged by 192.44% to $3.5 million in 2024, then crashed by 52.19% to $1.7 million in 2025.
  • Per Business Quant, the three most recent readings for CVSI's Cost of Revenue are $1.7 million (Q3 2025), $88000.0 (Q2 2025), and $731000.0 (Q1 2025).